The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (147.58) USD. With the latest stock price at 49.44 USD, the upside of Cytokinetics Inc based on DCF is -398.5%.
Based on the latest price of 49.44 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 398.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 10.1% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (474.52) - (91.19) | (147.58) |
| Upside | -1059.8% - -284.5% | -398.5% |